This article was originally published by Willow Tohi at Natural News.  The NIH funded the creation of a synthetic H5N1 hybrid virus using genetic material from multiple flu strains in European labs. The engineered virus was tested in ferrets in Alabama under live H5N1 challenge conditions. The project raises concerns about gain-of-function research and dual-use biosecurity risks. Private European biotech firms collaborated with U.S. agencies, signaling international coordination on pandemic preparedness. Critics warn of potential conflicts of interest, as NIH leaders stand to profit from future bird flu vaccine patents. The U.S. National Institutes of Health (NIH) has quietly funded…

Newswire

Features

The Latest